A detailed history of Exane Derivatives transactions in Hologic Inc stock. As of the latest transaction made, Exane Derivatives holds 1 shares of HOLX stock, worth $79. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 355 99.72%
Holding current value
$79
Previous $27,000 100.0%
% of portfolio
0.0%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$67.12 - $79.99 $23,760 - $28,316
-354 Reduced 99.72%
1 $0
Q1 2022

Apr 22, 2022

SELL
$68.08 - $76.82 $816 - $921
-12 Reduced 3.27%
355 $27,000
Q4 2021

Jan 28, 2022

SELL
$68.97 - $77.92 $6,276 - $7,090
-91 Reduced 19.87%
367 $28,000
Q3 2021

Oct 26, 2021

SELL
$67.56 - $80.74 $30,807 - $36,817
-456 Reduced 49.89%
458 $33,000
Q2 2021

Jul 28, 2021

SELL
$60.52 - $76.68 $56,949 - $72,155
-941 Reduced 50.73%
914 $60,000
Q1 2021

Apr 30, 2021

SELL
$68.76 - $83.72 $511,849 - $623,211
-7,444 Reduced 80.05%
1,855 $137,000
Q4 2020

Jan 27, 2021

BUY
$65.85 - $76.67 $95,284 - $110,941
1,447 Added 18.43%
9,299 $677,000
Q3 2020

Oct 06, 2020

BUY
$56.85 - $73.32 $23,649 - $30,501
416 Added 5.59%
7,852 $521,000
Q2 2020

Jul 10, 2020

BUY
$32.7 - $57.0 $243,157 - $423,852
7,436 New
7,436 $423,000

Others Institutions Holding HOLX

About HOLOGIC INC


  • Ticker HOLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 249,652,992
  • Market Cap $19.7B
  • Description
  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...
More about HOLX
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.